As of Dec 15
| +0.40 / +5.00%|
The 8 analysts offering 12-month price forecasts for Cytokinetics Inc have a median target of 15.00, with a high estimate of 19.00 and a low estimate of 10.00. The median estimate represents a +78.57% increase from the last price of 8.40.
The current consensus among 8 polled investment analysts is to Buy stock in Cytokinetics Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.